The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.
Open accessAbstract
Insulin-dependent diabetes (IDD) results from the autoimmune destruction of the insulin-producing pancreatic beta cells. Autoreactive T-lymphocytes are thought to play a pivotal role in the pathogenesis of IDD; however, the target antigens of these cells, as well as the inductive events in the disease, are unclear. PBMC in persons with or at increased risk for IDD show elevated reactivity to the beta cell enzyme glutamate decarboxylase (GAD). To identify the T-lymphocyte-reactive determinants of GAD, an overlapping set of synthetic peptides was used to stimulate the PBMC from these individuals, PBMC responsiveness to GAD peptides was not restricted to those with IDD, and a number of peptides elicited responses in PBMC. However, the major determinant of GAD recognized by persons at increased risk for IDD was amino acids 247-279, a region which has significant sequence similarity to the P2-C protein of Coxsackie B virus (47% of 15 increased risk [islet cell autoantibody-positive relatives]; 25% of 16 newly diagnosed IDD patients; and 0% of 13 healthy control subjects). Responses to tetanus and insulin antigens were not different between the study groups. In addition, PBMC from individuals responding to GAD peptides within 247-279 also responded to a Coxsackie viral peptide (i.e., P2-C amino acids 32-47), an observation supporting potential molecular mimicry in this immune response. Although the role of environmental agents in the pathogenesis of the disease remains unclear, these cellular immunological findings support the epidemiological evidence suggesting an inductive role for enteroviruses like Coxsackie B in the autoimmunity underlying IDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Measurement of T-cell reactivity in peripheral blood is theoretically appealing, but the imprecision of such assays precludes their use from a clinical setting (315,316).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [316]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baekkeskov, S., Aanstoot, H.-J., Christgai, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., & Camilli, P.-D. (1990) · Nature · doi:10.1038/347151a0 · Cited by 1,964
Kaufman, D. L., Clare-Salzler, M. J., Tian, J., Forsthuber, T. G., Ting, G. S. P., Robinson, P. J., Atkinson, M. A., Sercarz, E. E., Tobin, A. J., & Lehmann, P. (1993) · Nature · doi:10.1038/366069a0 · Cited by 1,057
Self-citationVirus-Induced Diabetes Mellitus
Yoon, J., Austin, M., Onodera, T., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197905243002102 · Cited by 1,017
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
Tisch, R., Yang, X., Singer, S. M., Liblau, R., Fugger, L. H., & McDevitt, H. O. (1993) · Nature · doi:10.1038/366072a0 · Cited by 946
Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat
Castano, L., & Eisenbarth, G. S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003243 · Cited by 644
Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus
Kaufman, D. L., Erlander, M. G., Clare-Salzler, M., Atkinson, M. A., Maclaren, N. K., & Tobin, A. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115573 · Cited by 490
Self-citationRUBELLA INFECTION AND DIABETES MELLITUS
Menser, M. A., Forrest, J., & Bransby, R. D. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90001-6 · Cited by 352
Bækkeskov, S., Aanstoot, H., Christgau, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F. B., Richter-Olesen, H., & Camilli, P. V. D. (1990) · Nature · doi:10.1038/347782a0 · Cited by 352
Riley, W. J., Maclaren, N. K., Krischer, J. P., Spillar, R. P., Silverstein, J. H., Schatz, D., Schwartz, S., Malone, J. I., Shah, S., Vadheim, C. M., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010253231704 · Cited by 284
Self-citationKarlsen, A. E., Hagopian, W., Grubin, C. E., Dube, S., Distèche, C. M., Adler, D. A., Bärmeier, H., Mathewes, S. L., Grant, F. J., & Foster, D. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8337 · Cited by 279
Flagged first, then by citations
Research works printed but not linked: 1
- Karlsen, A. E., W. A. Hagopian, C. E. Grubin, S. Dube, C. M. Disteche, D. A. Adler, H. Barmeier, S. Mathewes, F. J. Grant, D. Foster, and A. Lernmark. 1991. Cloning and primary structure of a human isoform of glutamic acid decar- boxylase. Proc. Nat. Acad. Sci. USA. 88:8337-8341.
Cited by
Sorted by citations
Items 401–448 of 448
L'isoforme de 65 kDa de l'acide glutamique décarboxylase (GAD65)
Rharbaoui, F., Bouanani, M., Pau, B., & Granier, C. (1998) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/s0923-2532(98)80006-9
Horwitz, M. S., & Sarvetnick, N. (1996) · Annales de l Institut Pasteur / Actualités · doi:10.1016/s0924-4204(97)85202-x
Characteristics of GADA in Type 1 Diabetes following Immunomodulation with GAD65
Chéramy, M. (2012) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Autoantibodies related to type 1 diabetes in children
Skoglund, C. (2011) · DiVA (Linkoping University)
Autoimmune markers in autoimmune diabetes
Gupta, M. (2003) · Figshare
Dietary insulin and the gut immune system in type 1 diabetes
Paronen, J. (2001) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
The Importance of CTLA-4 and HLA Class II for Type 1 Diabetes Immunology
Jonson, C. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Autoimmune Antigen Presentation Mechanisms
Dwyer, E. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1610-0_7
THE ROLE OF MAF TRANSCRIPTION FACTORS IN TYPE 1 DIABETES
Singh, T. (2013)
Molecular and Cellular Basis of Immune-Mediated (Type 1) Diabetes
Coutant, R., & Maclaren, N. K. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-697-3_16
Self-citationAttili, A., Ngwa, V. N., & Cuteri, V. (2014) · Unicam Scientific Publications (University of Camerino)
Odumosu, O. (2011) · The Scholars Repository - LLU (Loma Linda University)
Entérovirus et diabète de type 1.
Hober, D., Andréoletti, L., Hober, C., Belaïch, S., Vantyghem, M., Lefèbvre, J., & Wattré, P. (1998) · médecine/sciences · doi:10.4267/10608/1054
Immunology of b-Cell Destruction 37
Lernmark, Å., & Torre, D. L. (2015)
Anomalies in humoral immunity in the NOD mouse : contribution to the progression of type 1 diabetes
Thyagarajan, R. (2016) · DiVA at Umeå University (Umeå University)
Maternal and childhood enterovirus infections and the risk of Beta-cell autoimmunity
Sadeharju, K. (2005) · Tampere University Institutional Repository (Tampere University)
Miller, L. (2008) · UC Research Repository (University of Canterbury) · doi:10.26021/8577
Type 1 diabetes mellitus and enterovirus linkage: search for associated etiopathology
Nasir, I. A., Emeribe, A. U., Shuwa, H. A., Zakari, M. M., & Peters, N. O. (2017) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_25_17
Genetic and Immunologic Biomarkers in Type 1 Diabetes
Blanton, D. (2013)
Influencia de la terapia antidiabética en la respuesta al tratamiento de la disfunción eréctil
Gutiérrez, L. S. (2017) · Gredos (University of Salamanca) · doi:10.14201/gredos.137163
The genetic basis of T and B cell contribution to autoimmune diabetes in NOD mice
Motta, V. N. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
GAD65 An Immunomodulator in Type 1 Diabetes
Axelsson, S. (2012) · DiVA (Linkoping University)
Immunology of β-Cell Destruction
Lernmark, Å., & Torre, D. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_18-2
Brado, M., Bierhaus, A., Clemens, A., Dugi, K. A., Haass, M., Hammes, H., Herbay, A. V., Hofmann, M. A., Isermann, B., Kassessinoff, T. A., et al. (2001) · Springer eBooks · doi:10.1007/978-3-642-56784-1_16
Type 1 (Insulin-Dependent) Diabetes Mellitus
Delli, A. J., & Lernmark, Å. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00040-x
Immunology of β-Cell Destruction
Lernmark, Å., & Torre, D. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_18
Horwitz, M. S., & Sarvetnick, N. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0480
Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes
Lernmark, Å. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215381
Akel, O., & Lernmark, Å. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch14
Type 1 diabetes pathogenesis: lessons learned and remaining questions
Giwa, A., Yang, A., Majety, N., Ananth, K., Ahmed, R., Sadasivam, M., Behzadirad, M., Omidian, Z., Jackson, T. D., Donner, T. W., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91707-0.00003-6
SARS-CoV-2/COVID e Diabetes Mellitus Tipo 1
Andrade, L. J. D. O., Bittencourt, A. M. V., de Oliveira, L. M., de Oliveira, L. C. M., & de Oliveira, G. C. M. (2024) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v23i1.50821 · Cited by 1
Girdhar, K., Randall, A., Dogru, Y. D., Howard, C., Pezzella, A., Henao, J., Gautam, U. K., Ŝaŝinková, P., Hudcovic, T., Schwarzer, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.13.598927
Jönsson, J., & Lernmark, Å. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00176-9
Masuda, K., Yamamoto, K., & Aoki, N. (1996) · Folia Endocrinologica Japonica · doi:10.1507/endocrine1927.72.4_687
Regin in Blood Immune Regulation in Type 1 Diabetes
Pihl, M. (2013) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-98250
Glutamate Decarboxylase, GABA and Autoimmunity
Tobin, A. J., & Kaufman, D. L. (1996) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8990-2_4
Self-citationProtective Versus Harmful Responses and Immune Regulation
Rosa, F. D., & Barnaba, V. (1999) · Springer eBooks · doi:10.1007/978-88-470-2143-3_1
Dalakas, M. C. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90887-0.00009-2
Carré, A. (2022) · theses.fr (ABES) · doi:10.70675/28c85b2dz490az44c1zbbc4z061ea62b1e33
Molecular Mimicry and Determinant Spreading
Quinn, A., & Sercarz, E. E. (2014) · ASM Press eBooks · doi:10.1128/9781555818074.ch15
Clemens, A., Wahl, P. M., Klöppel, G., & Nawroth, P. (1999) · Springer eBooks · doi:10.1007/978-3-642-58588-3_3
Cytokines and Human Type 1 Diabetes
Kent, S. C., Viglietta, V., & Hafler, D. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-129-9_12
Metadata
- Authors
- Atkinson, M. A., Bowman, M. A., Campbell, L., Darrow, B. L., Kaufman, D. L., & Maclaren, N. K.
- Affiliations
- University of Florida (US)
- University of Florida Health (US)
- University of California, Los Angeles (US)
- ORCID
- Atkinson, M A
- Venue
- Journal of Clinical Investigation
- Published
- 1994-11-01
- Volume
- 94
- Issue
- 5
- Pages
- 2125-2129
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC294659
- OpenAlex
- W2138937703
- Cited by
- 448
- References
- 38
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 9 · 2023: 8 · 2022: 7 · 2021: 5 · 2020: 3 · 2019: 6 · 2018: 7 · 2017: 6 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 13 · 2012: 11
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- University of Florida
- National Institutes of Health (5r29dk045342-05)
- Centers for Disease Control and Prevention
- National Institute of Diabetes and Digestive and Kidney Diseases (R29DK45342)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- type 1 diabetes, glutamic acid decarboxylase, Coxsackie B virus, molecular mimicry, autoreactive T cells, islet autoimmunity, islet autoantibodies, enterovirus, pancreatic beta cells
- MeSH terms
- Adolescent, Adult, Amino Acid Sequence, Antibodies, Viral, Child, Diabetes Mellitus, Type 1, Enterovirus, Female, Glutamate Decarboxylase, Humans, Immunity, Cellular, Male, Middle Aged, Molecular Sequence Data, Peptide Fragments
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
